Projecting the direct cost burden of osteoarthritis in Canada using a microsimulation model

Osteoarthritis and Cartilage

Volumn 23, Issue 10, 2015, Pages 1654-1663

  Sharif, B ^a   Kopec, J ^b   Bansback, N ^b   Rahman, M M ^c,d   Flanagan, W M ^e   Wong, H ^b   Fines, P ^e   Anis, A ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^d EAST WEST UNIVERSITY   (Bangladesh)

^e STATISTICS CANADA   (Canada)

Author keywords

Cost of osteoarthritis; Direct cost; Microsimulation; Simulation modeling

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; CANADA; DRUG COST; FORECASTING; HEALTH CARE COST; HIP ARTHROPLASTY; HOME CARE; HOSPITAL UTILIZATION; HOSPITALIZATION COST; HUMAN; MEDICAL FEE; OSTEOARTHRITIS; OUTPATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RANDOM SAMPLE; REHABILITATION CARE; SIMULATION; TOTAL KNEE REPLACEMENT; AMBULATORY CARE; BRITISH COLUMBIA; COMPUTER SIMULATION; ECONOMICS; FACTUAL DATABASE; HOSPITALIZATION; PHYSIOTHERAPY; REPLACEMENT ARTHROPLASTY;

ANALGESIC AGENT;

AMBULATORY CARE; ANALGESICS; ARTHROPLASTY, REPLACEMENT; BRITISH COLUMBIA; CANADA; COMPUTER SIMULATION; DATABASES, FACTUAL; DRUG COSTS; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; OSTEOARTHRITIS; PHYSICAL THERAPY MODALITIES;

EID: 84940552520     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.05.029     Document Type: Article

References (49)

1. Yelin E. The economics of osteoarthritis. Osteoarthritis 1998, 23-30. Oxford University Press, New York. K. Brandt, M. Doherty, L.S. Lohmander (Eds.).
2. Bitton R. The economic burden of osteoarthritis. Am J Manag Care 2009 Sep, 15(8 Suppl):S230-S235.
3. Dibonaventura M.D., Gupta S., McDonald M., Sadosky A., Pettitt D., Silverman S. Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the national health and wellness survey. Health Qual Life Outcomes 2012 Mar, 10-30.
4. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2197-2223.
5. Yelin E., Murphy L., Cisternas M.G., Foreman A.J., Pasta D.J.H.C. Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997. Arthritis Rheum 2007, 56(5):1397-1407.
6. Maetzel A., Li L.C., Pencharz J. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 2004, 63:395-401.
7. Xie F., Thumboo J., Li S.-C. True difference or something else? Problems in cost of osteoarthritis studies. Semin Arthritis Rheum 2007, 37(2):127-132.
8. Akobundu E., Ju J., Blatt L., Mullins C.D. Cost-of-illness studies: a review of current methods. Pharmacoeconomics 2006, 24(9):869-890.
9. Murphy L.B., Helmick C.G., Cisternas M.G., Yellin E.H. Estimating medical costs attributable to osteoarthritis in the US population: comment on the article by Kotlarz et al. Arthritis Rheum 2010, 62(8):2566-2567.
10. Anis A.H., Zhang W., Bansback N., Guh D.P., Amarsi Z., Birmingham C.L. Obesity and overweight in Canada: an updated cost-of-illness study. Obes Rev 2010, 11(1):31-40.
11. Tarride J.E., Haq M., O'Reilly D.J., Bowen J.M., Xie F., Dolovich L., et al. The excess burden of osteoarthritis in the province of Ontario. Can Arthritis Rheum 2012, 64(4):1153-1161.
12. Rutter C.M., Zaslavsky A.M., Feuer E.J. Dynamic microsimulation models for health outcomes: a review. Med Decis Mak 2011, 31(1):10-18.
13. Hiligsmann M., Ethgen O., Bruyère O., Richy F., Gathon H.J., Reginster J.Y. Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value Health 2009, 12(5):678-696.
14. Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting. Diabetes Care 2007, 30(6):1638-1646. The Mount Hood 4 Modeling Group.
15. Vanness D.J., Tosteson A.N., Gabriel S.E., Melton L.J. The need for microsimulation to evaluate osteoporosis interventions. Osteoporos Int 2005 Apr, 16(4):353-358.
16. Kopec J.A., Sayre E.C., Flanagan W.M., Fines P., Cibere J., Rahman M.M., et al. Development of a population-based microsimulation model of osteoarthritis in Canada. Osteoarthritis Cartilage 2010 Mar, 18(3):303-311.
17. Zucchelli E., Jones A.M., Rice N. The evaluation of health policies through microsimulation methods 2010, HEDG working paper 10/03, University of York, [cited 2015 Feb 01]. Available from:. http://www.york.ac.uk/media/economics/documents/herc/wp/10_03.pdf.
18. Statistics Canada Canadian community health survey (CCHS) 2001, Microdata File User Guide, Health Statistics Division, Statistics Canada, Ottawa, Ontario, [cited 2015 April 10]. Available from:. http://www.statcan.gc.ca/eng/survey/household/3226.
19. Statistics Canada. The consumer price index. Ottawa, Canada [cited 2015 April 10]; Available from:. http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/econ46a-eng.htm.
20. Boardman A.E., Moore A.M., Vining A.R. The social discount rate for Canada based on future growth in consumption. Can Public Policy 2010, 36(3):325-343.
21. British Columbia Ministry of Health Medical services plan (MSP) payment information file 2011, V2. Population Data BC [publisher], Data Extract. MOH (2011) [cited 2015 April 10]. Available from:. http://www.popdata.bc.ca/data.
22. British Columbia Ministry of Health Discha Rge abstract database (Hospital separations) 2011, V2. Population Data BC [publisher], Data Extract. MOH (2011) [cited 2015 April 10]. Available from:. http://www.popdata.bc.ca/data.
23. British Columbia Ministry of Health Data extract. Data Stewardship Committee (2011) 2011, PharmaNet. V2. BC Ministry of Health [publisher], [cited 2015 April 10]. Available from:. http://www.popdata.bc.ca/data.
24. British Columbia Osteoarthritis Survey, Vancouver, Canada 2008, [cited 2015 Jan 10]. Available from: http://arthritis.rehab.med.ubc.ca/files/2011/08/BCOASurvey.pdf.
25. Canadian Institute of health Information (CIHI) Canadian joint replacement registry (CJRR) 2011, CIHI, [cited 2015 Jan 10]. Available from:. http://www.cihi.ca/CIHI-ext-portal/xlsx/internet/stats_cjrr2011_clinicaldata_en.
26. Canadian Institute of health Information (CIHI) CMG client tables 2011. DAD Acute inpatient data 2012, [cited 2015 Jan 10]. Available from:. https://secure.cihi.ca/estore/productFamily.htm?pf=PFC1627%26lang=en%26media=0.
27. Borsa J., Anis A. The cost of hospital care in Canada: a comparison of two alternatives. Healthc Manage Forum 2005, 18(1):19-27.
28. Canadian Institute for Health Information Hospital cost drivers technical report; what factors have determined hospital expenditure trends in Canada? 2010, Ottawa, Canada, [cited 2015 Jan 10]. Available from:. http://www.cihi.ca/cihi-ext-portal/pdf/internet/hospital_costdriver_tech_en.
29. Canadian Institute for Health Information Drivers of prescription drug spending in Canada 2012, Ottawa, Canada, [cited 2015 Jan 10]. Available from:. http://www.cihi.ca/CIHI-ext-portal/pdf/internet/DRUG_SPEND_DRIVERS_EN.
30. Canadian Institute for Health information Health care cost drivers: Physician Expenditure - Technical report spending and health workforce 2009, Ottawa, Canada, [cited 2015 Jan 10]. Available from: http://www.cihi.ca/cihi-ext-portal/pdf/internet/health_costdriver_phys_tech_en.
31. Canadian Institute for Health Information Average payment per physician report, Fee-for-service physicians in Canada 2004-2005 2006, National Physician Database, Ottawa, Canada, [cited 2015 Jan 10]. Available from:. https://secure.cihi.ca/free_products/app_average_payment_per_physician_report_2004_e.pdf.
32. Coyte P.C., Young W., Croxford R. Costs and outcomes associated with alternative discharge strategies following joint replacement surgery: analysis of an observational study using a propensity score. J Health Econ 2000, 19(6):907-929.
33. Oldmeadow L.B., Mcburney H., Robertson V.J. Predicting risk of extended inpatient rehabilitation after hip or knee arthroplasty. J Arthroplasty 2003, 18(6):775-779.
34. Gupta S., Hawker G.A., Laporte A., Croxford R., Coyte P.C. The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatol (Oxford) 2005, 44(12):1531-1537.
35. Patra J., Popova S., Rehm J., Bondy S., Flint R., Giesbrecht N. Economic cost of chronic disease in Canada 1995-2003 prepared for the Ontario Chronic Disease Prevention Alliance and the Ontario Public Health Association March 2007, [cited 2015 March 10]. Available from:. http://www.ocdpa.on.ca/sites/default/files/publications/OCDPA_EconomicCosts.pdf.
36. Losina E., Paltiel A.D., Weinstein A.M., Yelin E., Hunter D.J., Chen S.P., et al. Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty. Arthritis Care Res(Hoboken) 2015, 67(2):203-215.
37. Katz J.N. Total joint replacement in osteoarthritis. Best Pract Res Clin Rheumatol 2006, 20(1):145-153.
38. Ghomrawi H.M., Alexiades M., Pavlov H., Nam D., Endo Y., Mandl L.A., et al. Evaluation of two appropriateness criteria for total knee replacement. Arthritis Care Res (Hoboken) 2014, 66(11):1749-1753.
39. Riddle D.L., Jiranek W.A., Hayes C.W. Use of a validated algorithm to judge the appropriateness of total knee arthroplasty in the United States: a multicenter longitudinal cohort study. Arthritis Rheumatol 2014, 66(8):2134-2143.
40. Hawker G.A., Wright J.G., Glazier R.H., Coyte P.C., Harvey B., Williams J.I., et al. The effect of education and income on need and willingness to undergo total joint arthroplasty. Arthritis Rheumatol 2002, 46(12):3331-3339.
41. Gruber W.H., Hunter D.J. Transforming osteoarthritis care in an era of health care reform. Clin Geriatr Med 2010, 26(3):433-444.
42. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16(2):137-162.
43. Canadian Institute of Health Information (CIHI) Health care cost drivers: The facts October 2011, Ottawa, Canada, [cited 2015 March 10]. Available from:. https://secure.cihi.ca/free_products/health_care_cost_drivers_the_facts_en.pdf.
44. Clegg D.O., Reda D.J., Harris C.L., Clegg D.O., Reda D.J., Harris C.L., et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006, 354(8):795-798.
45. Losina E., Daigle M.E., Suter L.G., Hunter D.J., Solomon D.H., Walensky R.P., et al. Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?. Osteoarthritis Cartilage 2013, 21(5):655-667.
46. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007 Sep, 15(9):981-1000.
47. Patra J., Popova S., Rehm J., Bondy S., Flint R., Giesbrecht N. Economic cost of chronic disease in Canada 1995-2003 2007(March), 1-37. Health Canada, [cited 2015 April 01]. Available from:. http://ocdpa.ca/sites/default/files/publications/OCDPA_EconomicCosts.pdf.
48. Statistics Canada. The Life paths model [cited 2015 March 10]. Available from:. http://www.statcan.gc.ca/eng/microsimulation/lifepaths/overview/.
49. Direct cost of osteoarthritis in Canada : an Application of Microsimulation Modeling with Uncertainty Analysis- Sharif Behnam, University of British Columbia, PhD thesis, [cited 2015 April 01]. Available from:. https://circle.ubc.ca/handle/2429/46614.